| BRISTOL-MYERS SQUIBBDL-10 |
| USA |
| Gesundheit |
| US1101221083 / 850501 |
| BRM (Frankfurt) / BMY (NYSE) |
| FRA:BRM, ETR:BRM, BRM:GR, NYSE:BMY |
| S&P500 |
| https://www.bms.com/ |
|
Bristol-Myers Squibb Company is a global biopharmaceutical company headquartered in Princeton, New Jersey, and founded in 1933. It discovers, develops, licenses, manufactures, markets, distributes, and sells innovative medicines addressing serious di..
>Volltext.. |
| 100853.71 Mio. EUR |
| 132015.26 Mio. EUR |
| 41911.89 Mio. EUR |
| 16471.01 Mio. EUR |
| 6289.12 Mio. EUR |
| 3.09 EUR |
| 40137.11 Mio. EUR |
| 8276.57 Mio. EUR |
| 11502.82 Mio. EUR |
| 0.55 |
| -4.7% |
| 25.71% |
| 2.15 EUR |
| 4.39% |
| 4.42% |
| 02.04.26 - 0.546777€ 02.01.26 - 0.5355€ >weitere anzeigen... |
| - |
| BRISTOL-MYERS, BRISTOL MYERS |
| 16.06.26 |
|